Literature DB >> 17485116

Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation.

Merel C M Strik1, Pieter J A de Koning, Monique J Kleijmeer, Bellinda A Bladergroen, Angela M Wolbink, Janice M Griffith, Dorine Wouters, Yoshihiro Fukuoka, Lawrence B Schwartz, C Erik Hack, S Marieke van Ham, J Alain Kummer.   

Abstract

Mast cells are widely distributed throughout the body and express effector functions in allergic reactions, inflammatory diseases, and host defense. Activation of mast cells results in exocytosis of preformed chemical mediators and leads to novel synthesis and secretion of lipid mediators and cytokines. Here, we show that human mast cells also express and release the cytotoxic lymphocyte-associated protease, granzyme B. Granzyme B was active and localized in cytoplasmic granules, morphologically resembling those present in cytotoxic lymphocytes. Expression and release of granzyme B by mast cell-lines HMC-1 and LAD 2 and by cord blood- and mature skin-derived human mast cells depended on the mode of activation of these cells. In mast cell lines and cord blood-derived mast cells, granzyme B expression was mainly induced by non-physiological stimuli (A23187/PMA, Compound 48/80) and substance P. In contrast, mature skin-derived mast cells only produced granzyme B upon IgE-dependent stimulation. We conclude that granzyme B is expressed and released by human mast cells upon physiologic stimulation. This suggests a role for granzyme B as a novel mediator in mast cell biology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485116     DOI: 10.1016/j.molimm.2007.03.024

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  36 in total

Review 1.  Death by a thousand cuts: granzyme pathways of programmed cell death.

Authors:  Dipanjan Chowdhury; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

2.  Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma.

Authors:  Elly Marcq; Vasiliki Siozopoulou; Jorrit De Waele; Jonas van Audenaerde; Karen Zwaenepoel; Eva Santermans; Niel Hens; Patrick Pauwels; Jan P van Meerbeeck; Evelien L J Smits
Journal:  Oncoimmunology       Date:  2016-11-28       Impact factor: 8.110

3.  Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α.

Authors:  Inna S Afonina; Graham A Tynan; Susan E Logue; Sean P Cullen; Michael Bots; Alexander U Lüthi; Emer P Reeves; Noel G McElvaney; Jan P Medema; Ed C Lavelle; Seamus J Martin
Journal:  Mol Cell       Date:  2011-10-21       Impact factor: 17.970

Review 4.  Beyond apoptosis: the mechanism and function of phosphatidylserine asymmetry in the membrane of activating mast cells.

Authors:  Noel M Rysavy; Lori M N Shimoda; Alyssa M Dixon; Mark Speck; Alexander J Stokes; Helen Turner; Eric Y Umemoto
Journal:  Bioarchitecture       Date:  2014

Review 5.  Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing.

Authors:  Jeffrey Douaiher; Julien Succar; Luca Lancerotto; Michael F Gurish; Dennis P Orgill; Matthew J Hamilton; Steven A Krilis; Richard L Stevens
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

6.  Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.

Authors:  Emma Lefrançais; Anais Duval; Emilie Mirey; Stéphane Roga; Eric Espinosa; Corinne Cayrol; Jean-Philippe Girard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

7.  Sinonasal T-cell expression of cytotoxic mediators granzyme B and perforin is reduced in patients with chronic rhinosinusitis.

Authors:  Sarah E Smith; Rodney J Schlosser; James R Yawn; Jose L Mattos; Zachary M Soler; Jennifer K Mulligan
Journal:  Am J Rhinol Allergy       Date:  2017-11-01       Impact factor: 2.467

8.  A colorimetric assay that specifically measures Granzyme B proteolytic activity: hydrolysis of Boc-Ala-Ala-Asp-S-Bzl.

Authors:  Magdalena Hagn; Vivien R Sutton; Joseph A Trapani
Journal:  J Vis Exp       Date:  2014-11-28       Impact factor: 1.355

9.  Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion.

Authors:  Bernd Jahrsdörfer; Angelika Vollmer; Sue E Blackwell; Julia Maier; Kai Sontheimer; Thamara Beyer; Birgit Mandel; Oleg Lunov; Kyrylo Tron; G Ulrich Nienhaus; Thomas Simmet; Klaus-Michael Debatin; George J Weiner; Dorit Fabricius
Journal:  Blood       Date:  2009-12-03       Impact factor: 22.113

10.  Granule exocytosis of granulysin and granzyme B as a potential key mechanism in vaccine-induced immunity in cattle against the nematode Ostertagia ostertagi.

Authors:  Frederik Van Meulder; Stefanie Van Coppernolle; Jimmy Borloo; Manuela Rinaldi; Robert W Li; Koen Chiers; Wim Van den Broeck; Jozef Vercruysse; Edwin Claerebout; Peter Geldhof
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.